SC Filed 2020-05-18 Event — SEC 0000919574-20-003743 →

Casdin Capital, LLC → GenMark Diagnostics, Inc.

Stake: — Shares: —

Composite Decision Signal · PASS (LOW BASE-RATE EDGE) Conviction Score: 8/100 · Filer 90d Win Rate: 33% · Hist. 90d Edge: +5.5%

Filer track record (5 filings): 33% 90d win rate, +5.5% 90d edge

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

2 13D/G filings on this issuer

1 other filing besides this one

Filer Track Record

12 filings by this filer

11 other filings in the data moat

Short Interest

—

Not in latest FINRA snapshot

Other 13D/G Filings on GenMark Diagnostics, Inc.

Filed	Form	Filer	Stake	Shares
2020-02-07	SC	Casdin Capital, LLC	—	—	view →

Other Filings by Casdin Capital, LLC

Filed	Form	Issuer	Stake	Shares
2026-06-09	SCHEDULE 13D/A	Standard BioTools Inc. LAB	23.90%	88,783,856	view →
2026-06-04	SCHEDULE 13G	BIOLIFE SOLUTIONS INC BLFS	—	—	view →
2026-05-22	SCHEDULE 13D/A	BIOLIFE SOLUTIONS INC BLFS	9.70%	4,757,165	view →
2025-08-13	SCHEDULE	BIOLIFE SOLUTIONS INC BLFS	15.00%	7,207,165	view →
2025-03-07	SCHEDULE	Tenaya Therapeutics, Inc. TNYA	4.30%	6,732,971	view →
2025-03-04	SCHEDULE	STANDARD BIOTOOLS INC. LAB	21.60%	80,864,315	view →
2024-01-09	SC	STANDARD BIOTOOLS INC. LAB	—	—	view →
2023-03-20	SC	Absci Corp ABSI	—	—	view →
2022-11-28	SC	Tenaya Therapeutics, Inc. TNYA	—	—	view →
2022-10-11	SC	Century Therapeutics, Inc. IPSC	—	—	view →
2020-02-07	SC	GenMark Diagnostics, Inc.	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.

See pricing →